GC Biopharma Corp. (006280) Price & Analysis

― Followers

006280 Stock Chart & Stats

$130100.00

$2,700.00(2.12%)

Sep 10, 2026

―

Day’s Range― - ―

52-Week Range$105,900.00 - $183,800.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)29.10K

Market Cap

₩1.45T

Enterprise Value$2.36M

Total Cash (Recent Filing)₩44.66B

Total Debt (Recent Filing)₩938.85B

Price to Earnings (P/E)―

Beta0.23

Next Earnings

Nov 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.15%

Share Statistics

EPS (TTM)-4372.16

Shares Outstanding11,686,538

10 Day Avg. Volume16,088

30 Day Avg. Volume29,101

Financial Highlights & Ratios

PEG Ratio4.72

Price to Book (P/B)1.49

Price to Sales (P/S)0.91

P/FCF Ratio66.97

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)22,633.6

Revenue Forecast (FY)₩1.99T

006280 FAQ

What was GC Biopharma Corp.’s price range in the past 12 months?

GC Biopharma Corp. lowest stock price was $105900.00 and its highest was $183800.00 in the past 12 months.

What is GC Biopharma Corp.’s market cap?

GC Biopharma Corp.’s market cap is ₩1.45T.

When is GC Biopharma Corp.’s upcoming earnings report date?

GC Biopharma Corp.’s upcoming earnings report date is Nov 03, 2026 which is in 53 days.

How were GC Biopharma Corp.’s earnings last quarter?

GC Biopharma Corp. released its earnings results on Jul 31, 2026. The company reported $973.79 earnings per share for the quarter.

Is GC Biopharma Corp. overvalued?

According to Wall Street analysts GC Biopharma Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does GC Biopharma Corp. pay dividends?

GC Biopharma Corp. pays a Notavailable dividend of $1500 which represents an annual dividend yield of 1.15%. See more information on GC Biopharma Corp. dividends here

What is GC Biopharma Corp.’s EPS estimate?

GC Biopharma Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does GC Biopharma Corp. have?

GC Biopharma Corp. has 11,686,538 shares outstanding.

What happened to GC Biopharma Corp.’s price movement after its last earnings report?

GC Biopharma Corp. reported an EPS of $973.79 in its last earnings report. Following the earnings report the stock price went up 1.489%.

Which hedge fund is a major shareholder of GC Biopharma Corp.?

Currently, no hedge funds are holding shares in KR:006280

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

GC Biopharma Corp.

GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.